Navigation Links
'Freezing' Secondary Breast Cancer Tumors Shows Promise
Date:3/26/2012

MONDAY, March 26 (HealthDay News) -- In a small and preliminary study, researchers report that they successfully froze secondary tumors in patients with incurable breast cancer.

The findings raise the prospect of a potential new treatment for metastatic tumors in individual patients, although the research is in the very early stages.

"This therapy provides a minimal rate of cancer recurrence and no major complications," study co-author Dr. Peter Littrup, director of imaging core and radiology research at the Karmanos Cancer Institute in Detroit, said in a news release from the Society of Interventional Radiology.

The study is scheduled to be presented Wednesday at the society's annual meeting in San Francisco. Research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed medical journal.

"This is a preliminary study, and at this point we're hoping that the evidence could be a stepping stone for a bigger study to look at more patients," Littrup said. "If we can get more data that supports percutaneous cryoablation for metastatic breast cancer, it could be a huge finding."

In percutaneous cryoablation, tiny probes insert pressurized argon gas into tumors and kill them by turning them into balls of ice.

The eight patients in the study had stage 4 metastatic breast cancer, meaning their tumors had spread widely from the breast. The tumors frequently appear in organs such as the liver, lungs, bones and kidneys.

In stage 4, the disease is considered incurable.

"At this point, treatments are considered palliative -- with the intent to keep metastases at bay while hopefully providing individuals more time and improved quality of life, rather than a complete cure," Littrup said.

"Cryoablation as a targeted therapy is beneficial because it can significantly reduce discomfort and incidence of disease," Littrup said. "It's a much better option, we think,
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Wayne State proves targeted tumor freezing therapy increases ovarian cancer survival
2. Freezing Wrinkles a Possible Alternative to Botox
3. For Common Warts, Freezing Therapy Works Best: Study
4. Studies of womens attitudes to social egg freezing find reasons differ with age
5. Freezing Tumors Shows Promise Against Prostate, Breast Cancer
6. Freezing, Medicating Away a Dangerous Irregular Heart Rhythm
7. Freezing Technique May Stop Breast Cancer
8. Freezing breast tumors helps stop cancer’s spread in mice, U-M study finds
9. Malnutrition as a secondary symptom
10. Researchers focus on secondary stroke prevention after study reveals room for improvement
11. Urgent steps needed to tackle inadequate support for women with secondary breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Freezing' Secondary Breast Cancer Tumors Shows Promise
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) ... LLP reports. According to an Order issued in the ... 20th, the Court will convene an open conference on ... Building and United States Courthouse in West Palm Beach, ...
(Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
(Date:12/25/2014)... 26, 2014 Recently, iFitDress.com, the popular online ... has announced its new selection of black one-shoulder cocktail ... sale now; they are available at discounted prices, up to ... promotion will last for three weeks only. You know, we ... who are interested in our new items can visit our ...
(Date:12/25/2014)... 26, 2014 Recently, Dylan Queen, a ... excitedly released its collection of discounted prom dresses, most ... a senior spokesman of the company, the promotion is ... promotion is to expand the UK market. , The ... different colors, lengths, and styles: A-line strapless, empire strapless ...
(Date:12/25/2014)... Los Angeles, CA (PRWEB) December 25, 2014 ... Blaise Dolcemaschio was created in honor of a true ... premiere at two film festivals including the 24 hours of ... Film Festival in Bangladesh. , Actress, screenwriter and ... and helped produce this film together with her husband, ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
... Kabi Pty Ltd, one of Australia,s fastest growing and ... (Robotic IV Automation) - a self-contained unit for filling ... (IH Systems) to consolidate its IV preparation. Pharmatel Fresenius ... in June 2009. , The RIVA System and Pharmatel ...
... Feb. 11 Naturs Design, Inc., a privately held ... the revolutionary product that virtually eliminates all of the ... for sleep apnea. Unfortunately, CPAP therapy hasn,t always been ... reports that "many CPAP users never continue therapy beyond ...
... Gynecologic Oncologists, 40th Annual Meeting on Women,s Cancer Proves ... Pa., Feb. 11 New data presented on Saturday ... Oncologists, 40th Annual Meeting on Women,s Cancer demonstrated the ... CA125 blood test results and the Risk of Ovarian ...
... 11 Rising Medical Solutions, Inc. (Rising), ... management organization, announced today that it has ... Accreditation from URAC, a Washington, DC-based health ... quality standards for the health care industry.(Logo: ...
... announced today that Laurence Debroux is ... (CSO).In light of the implementation of the Group,s ... the position of Chief Strategic Officer at the ... business development and acquisition activities as well as ...
... Feb. 11 The Quantum Group, Inc. ( NYSE ... that Pete Martinez, Senior Vice President and Chief Technology ... the St. Thomas University Healthcare Seminar later ... Economic Times." Martinez will contribute to the event ...
Cached Medicine News:Health News:Australia's Leading Oncology Drug Compounder Chooses RIVA System 2Health News:Husband From Small Town May Have Found Solution to Sleep Industry's 20-Year Compliance Problem 2Health News:Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer 2Health News:Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer 3Health News:Rising Medical Solutions Receives URAC Workers' Compensation Utilization Management Accreditation 2Health News:Rising Medical Solutions Receives URAC Workers' Compensation Utilization Management Accreditation 3Health News:Laurence Debroux Appointed Chief Strategic Officer (CSO) 2Health News:Quantum Executive Pete Martinez Invited to Participate in University Health Seminar 2Health News:Quantum Executive Pete Martinez Invited to Participate in University Health Seminar 3Health News:Quantum Executive Pete Martinez Invited to Participate in University Health Seminar 4
(Date:12/24/2014)... , Dec. 24, 2014 /CNW/ - ... is being recalled after Health Canada tests confirmed it ... health risks (beta-methylphenethylamine and phenylpropylmethylamine). The distributor, Empire Health ... recalling the product from retail stores across ... building purposes, including for weight loss and increased energy. ...
(Date:12/24/2014)... Dec. 24, 2014  Novastem, a leader in ... patient in its study for ischemic stroke at ... Association, ischemic strokes account for 87 percent of ... patients in the study, entitled "Internal Research Protocol ... Mesenchymal Stem Cells and Intrathecal Administration of Neural ...
(Date:12/24/2014)... -- Actavis plc (NYSE: ACT ) today ... response letter from the U.S. Food and Drug ... for the fixed-dose combination (FDC) of nebivolol and ... Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... a complete response letter, Actavis remains committed to ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4
... Corporation (NYSE: SYK ) reported operating results for ... Third Quarter Highlights Net sales ... to $1,768 million Orthopaedic Implants sales increased 1.3% on ... Equipment sales increased 16.3% on a constant currency basis (16.1% ...
... Calif., Oct. 19 ThermoGenesis Corp. (Nasdaq: ... services that process and store adult stem cells, said ... agreement for its Res-Q™ 60 BMC (Res-Q) System with ... point-of-care cardiovascular therapies. Under the agreement, ...
Cached Medicine Technology:Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 2Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 3Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 4Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 5Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 6Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 7Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 8ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement 2ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement 3
For children up to 4 years of age 11 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
... capture and management system that acquires extremely ... Angiography images. It interfaces with most current ... from any ophthalmic device with video, digital ... the features of EyeCap RI, with further ...
The Haag-Streit 81 D lens is a powerful tool for biomicroscopy as well as laser treatment of the fundus. Due to its asymmetric configuration it provides better observation parameters combined with im...
... mirrored surfaces, which each incline at an ... have been cut into the 17 mm ... to examine the opposite iridocorneal angle without ... form of the angle of the iris ...
Medicine Products: